Interestingly, while a significant reduction of the tumor mass was observed, the authors could not evidence any increase of CD45+, CD3+/CD4+, and CD3+/CD8+ infiltrating cells in the whole tumor. The gene discussed is PTPRC; the disease is neoplasm.